EHMTI-0102. Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK
Crossref DOI link: https://doi.org/10.1186/1129-2377-15-S1-G19
Published Online: 2014-09-18
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Khalil, M
Zafar, H
Quarshie, V
Ahmed, F
License valid from 2014-09-18